We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Foggs MD

Michael Foggs MD

President, American College of Allergy, Asthma & Immunology (ACAAI); Chief, Allergy/Immunology, Advocate Medical Group, Advocate Health Care, Chicago, Illinois; Chief Medical Officer, 540 Protection, LLC, Glen Ellyn, Ilinois

Dr. Foggs is President of the American College of Allergy, Asthma & Immunology (ACAAI). Dr. Foggs is chief of allergy & immunology, Advocate Medical Group of Advocate Health Care in Chicago, and chief medical Officer for 540 Protection, LLC, Glen Ellyn, IL.

He is a member of the United States Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee (PADAC) and received its Distinguished Service Award. He serves on the Consensus Panel on Asthma in the African American Community of the National Medical Association, and serves on the Board of Directors of InterAsma Global Asthma Association. Formerly, he served on the Expert Panel 3 of the National Heart Lung and Blood Institute's National Asthma Education Prevention Program; on the National Institutes of Health Asthma Outcomes Workshop Quality of Life Committee; and on the World Allergy Organization’s Asthma Special Committee. He was honored with the ACAAI's Distinguished Fellow Award, the Stanislaus Jaros Lectureship, and the Bela Schick Lectureship. He was also honored with the Alvin F. Poussaint, M.D. Visiting Lectureship at Harvard Medical School in 2013.